zoledronic acid has been researched along with CKD-MBD in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavarot, N; Flamant, M; Tabibzadeh, N; Vidal-Petiot, E | 1 |
| Delling, G; Grampp, S; Haas, M; Klaushofer, K; Kletzmayr, J; Leko-Mohr, Z; Mitterbauer, C; Oberbauer, R; Roschger, P; Schwarz, C; Steininger, R | 1 |
| Haas, M; Heinze, G; Mitterbauer, C; Oberbauer, R; Schwarz, C; Woloszczuk, W | 1 |
2 trial(s) available for zoledronic acid and CKD-MBD
| Article | Year |
|---|---|
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.
Topics: Biomarkers; Bone Density; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Diphosphonates; Female; Femur Neck; Humans; Imidazoles; Kidney Transplantation; Lumbar Vertebrae; Male; Middle Aged; Postoperative Complications; Zoledronic Acid | 2003 |
Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation.
Topics: Acute Disease; Biomarkers; Bone Density; Calcification, Physiologic; Chronic Kidney Disease-Mineral and Bone Disorder; Diphosphonates; Femur; Graft Rejection; Humans; Imidazoles; Kidney Transplantation; Osteoblasts; Osteoclasts; Zoledronic Acid | 2004 |
1 other study(ies) available for zoledronic acid and CKD-MBD
| Article | Year |
|---|---|
Biphosphonate Therapy, Risk of Fracture, and Sites of Bone Mineral Density Assessments in Kidney Transplantation.
Topics: Bone Density; Chronic Kidney Disease-Mineral and Bone Disorder; Fractures, Bone; Humans; Kidney Transplantation; Zoledronic Acid | 2019 |